Item Type | Name |
Concept
|
Thromboembolism
|
Concept
|
Venous Thromboembolism
|
Academic Article
|
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
|
Academic Article
|
The economics of venous thromboembolism prophylaxis: a primer for clinicians.
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
Academic Article
|
Oral rivaroxaban for symptomatic venous thromboembolism.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
Academic Article
|
Apixaban for extended treatment of venous thromboembolism.
|
Academic Article
|
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
|
Academic Article
|
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.
|
Academic Article
|
The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.
|
Academic Article
|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
|
Academic Article
|
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
Academic Article
|
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
Academic Article
|
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
|
Academic Article
|
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Anticoagulant therapy for venous thromboembolism.
|
Academic Article
|
A new noninvasive management strategy for patients with suspected pulmonary embolism.
|
Academic Article
|
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
|
Academic Article
|
Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
|
Academic Article
|
Treatment of venous thromboembolism.
|
Academic Article
|
Low molecular weight heparin, heparin, and warfarin.
|
Academic Article
|
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
Academic Article
|
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
|
Academic Article
|
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
|
Academic Article
|
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
Academic Article
|
Global public awareness of venous thromboembolism.
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
Academic Article
|
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
|
Academic Article
|
Global public awareness of venous thromboembolism: reply.
|
Academic Article
|
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
|
Academic Article
|
New paradigms in venous thromboprophylaxis of medically ill patients.
|
Academic Article
|
Edoxaban for Cancer-Associated Venous Thromboembolism.
|
Academic Article
|
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
|
Academic Article
|
Clinical implications of incidental venous thromboembolism in cancer patients.
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
|
Academic Article
|
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
|
Academic Article
|
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
|
Academic Article
|
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.
|
Academic Article
|
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
Academic Article
|
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
Academic Article
|
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
|
Academic Article
|
Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.
|
Academic Article
|
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
|
Academic Article
|
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
|
Academic Article
|
Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
Academic Article
|
Oral apixaban for the treatment of acute venous thromboembolism.
|
Academic Article
|
Long-term anticoagulant therapy prevents recurrent venous thromboembolism.
|
Academic Article
|
Oral anticoagulants: new and improved.
|
Academic Article
|
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial.
|
Academic Article
|
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
Academic Article
|
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.
|
Academic Article
|
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
|
Academic Article
|
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
|
Academic Article
|
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.
|
Academic Article
|
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
Academic Article
|
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
|
Academic Article
|
Prevention and treatment of venous thromboembolism--International Consensus Statement.
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
Academic Article
|
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
|
Academic Article
|
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial.
|
Academic Article
|
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
|
Academic Article
|
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
Academic Article
|
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
|
Academic Article
|
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
|
Academic Article
|
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
|
Academic Article
|
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
|
Academic Article
|
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
|
Academic Article
|
Thromboprophylaxis after Hospitalization for Medical Illness.
|
Academic Article
|
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
Academic Article
|
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
|
Academic Article
|
Diagnosis and management of pulmonary thromboembolism.
|
Academic Article
|
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
|
Academic Article
|
Prophylaxis of venous thromboembolic disease following hip and knee surgery.
|
Academic Article
|
Prophylaxis of venous thromboembolism. An overview.
|
Grant
|
ACTIVE SURVEILLANCE FOR VENOUS THROMBOEMBOLISM IN A RACIALLY DIVERSE POPULATION
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism. Reply.
|
Academic Article
|
Milvexian for the Prevention of Venous Thromboembolism.
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism.
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
Academic Article
|
Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis.
|
Academic Article
|
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
|
Academic Article
|
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
|
Academic Article
|
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
|
Academic Article
|
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
|
Academic Article
|
Cancer-associated venous thromboembolism: Incidence and features in a racially diverse population.
|
Academic Article
|
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
|
Academic Article
|
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
|
Academic Article
|
Redefining clinical venous thromboembolism phenotypes: a?novel approach using latent class analysis.
|
Academic Article
|
Exploring the Applicability of Using Natural Language Processing to Support Nationwide Venous Thromboembolism Surveillance: Model Evaluation Study.
|